Robotic colposuspension for female stress urinary incontinence: a prospective series
BAUS ePoster online library. Tan N. 06/21/21; 319092; p5-4
Disclosure(s): N.A
Mr. Nataniel Tan
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction
Open and Laparoscopic Colposuspension are well recognised treatment modalities for female urodynamic SUI. We report on the outcomes of a new service of Robotic-assisted laparoscopic colposuspension at a London Tertiary Hospital.
Patients and Methods
A prospective review of all patients was conducted from April 2019 to November 2020 at a tertiary London hospital. Prospective data on demographic details, pre-operative and post-operative pad usage, and urinary incontinence short form and overactive bladder questionnaires (ICIQ-UI-SF) and (ICIQ-OAB) were gathered to assess symptom severity and impact on quality of life. Information on patient satisfaction was acquired through PG-II scores.
Results
24 patients were identified, with a mean age and BMI of 49 years and 28kg/m2 respectively. The Mean follow-up period was 10 months(range 1-18 months). 16(66.7%) patients had pure SUI, while 8(33.3%) patients had mixed urinary incontinence (MUI). 8(33%) were recurrent SUI after previous SUI treatment.
Mean 24hour pad use reduced from 4.9 pre-procedure to 1.3 pads post-procedure whilst mean ICIQ-UI-SF scores improved from 17.6 pre-operatively to 9.6. These were significant changes using paired t-tests for ICIQ-UI-SF scores (p=0.001) and pad usage (p=0.001). There was no significant change in the mean ICIQ-OAB scores from 6.0 pre-procedure to 5.0 post-procedure. Mean Length of stay was 2 nights.
Conclusions
This report is the largest UK series to date of its kind. There was significant improvement in pad usage and quality-of-life scores. Robotic Colposuspension is a feasible treatment option for female SUI, and will need a longer term evaluation with a larger volume of patients.
Open and Laparoscopic Colposuspension are well recognised treatment modalities for female urodynamic SUI. We report on the outcomes of a new service of Robotic-assisted laparoscopic colposuspension at a London Tertiary Hospital.
Patients and Methods
A prospective review of all patients was conducted from April 2019 to November 2020 at a tertiary London hospital. Prospective data on demographic details, pre-operative and post-operative pad usage, and urinary incontinence short form and overactive bladder questionnaires (ICIQ-UI-SF) and (ICIQ-OAB) were gathered to assess symptom severity and impact on quality of life. Information on patient satisfaction was acquired through PG-II scores.
Results
24 patients were identified, with a mean age and BMI of 49 years and 28kg/m2 respectively. The Mean follow-up period was 10 months(range 1-18 months). 16(66.7%) patients had pure SUI, while 8(33.3%) patients had mixed urinary incontinence (MUI). 8(33%) were recurrent SUI after previous SUI treatment.
Mean 24hour pad use reduced from 4.9 pre-procedure to 1.3 pads post-procedure whilst mean ICIQ-UI-SF scores improved from 17.6 pre-operatively to 9.6. These were significant changes using paired t-tests for ICIQ-UI-SF scores (p=0.001) and pad usage (p=0.001). There was no significant change in the mean ICIQ-OAB scores from 6.0 pre-procedure to 5.0 post-procedure. Mean Length of stay was 2 nights.
Conclusions
This report is the largest UK series to date of its kind. There was significant improvement in pad usage and quality-of-life scores. Robotic Colposuspension is a feasible treatment option for female SUI, and will need a longer term evaluation with a larger volume of patients.
Introduction
Open and Laparoscopic Colposuspension are well recognised treatment modalities for female urodynamic SUI. We report on the outcomes of a new service of Robotic-assisted laparoscopic colposuspension at a London Tertiary Hospital.
Patients and Methods
A prospective review of all patients was conducted from April 2019 to November 2020 at a tertiary London hospital. Prospective data on demographic details, pre-operative and post-operative pad usage, and urinary incontinence short form and overactive bladder questionnaires (ICIQ-UI-SF) and (ICIQ-OAB) were gathered to assess symptom severity and impact on quality of life. Information on patient satisfaction was acquired through PG-II scores.
Results
24 patients were identified, with a mean age and BMI of 49 years and 28kg/m2 respectively. The Mean follow-up period was 10 months(range 1-18 months). 16(66.7%) patients had pure SUI, while 8(33.3%) patients had mixed urinary incontinence (MUI). 8(33%) were recurrent SUI after previous SUI treatment.
Mean 24hour pad use reduced from 4.9 pre-procedure to 1.3 pads post-procedure whilst mean ICIQ-UI-SF scores improved from 17.6 pre-operatively to 9.6. These were significant changes using paired t-tests for ICIQ-UI-SF scores (p=0.001) and pad usage (p=0.001). There was no significant change in the mean ICIQ-OAB scores from 6.0 pre-procedure to 5.0 post-procedure. Mean Length of stay was 2 nights.
Conclusions
This report is the largest UK series to date of its kind. There was significant improvement in pad usage and quality-of-life scores. Robotic Colposuspension is a feasible treatment option for female SUI, and will need a longer term evaluation with a larger volume of patients.
Open and Laparoscopic Colposuspension are well recognised treatment modalities for female urodynamic SUI. We report on the outcomes of a new service of Robotic-assisted laparoscopic colposuspension at a London Tertiary Hospital.
Patients and Methods
A prospective review of all patients was conducted from April 2019 to November 2020 at a tertiary London hospital. Prospective data on demographic details, pre-operative and post-operative pad usage, and urinary incontinence short form and overactive bladder questionnaires (ICIQ-UI-SF) and (ICIQ-OAB) were gathered to assess symptom severity and impact on quality of life. Information on patient satisfaction was acquired through PG-II scores.
Results
24 patients were identified, with a mean age and BMI of 49 years and 28kg/m2 respectively. The Mean follow-up period was 10 months(range 1-18 months). 16(66.7%) patients had pure SUI, while 8(33.3%) patients had mixed urinary incontinence (MUI). 8(33%) were recurrent SUI after previous SUI treatment.
Mean 24hour pad use reduced from 4.9 pre-procedure to 1.3 pads post-procedure whilst mean ICIQ-UI-SF scores improved from 17.6 pre-operatively to 9.6. These were significant changes using paired t-tests for ICIQ-UI-SF scores (p=0.001) and pad usage (p=0.001). There was no significant change in the mean ICIQ-OAB scores from 6.0 pre-procedure to 5.0 post-procedure. Mean Length of stay was 2 nights.
Conclusions
This report is the largest UK series to date of its kind. There was significant improvement in pad usage and quality-of-life scores. Robotic Colposuspension is a feasible treatment option for female SUI, and will need a longer term evaluation with a larger volume of patients.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}